NNVC
Price:
$1.22
Market Cap:
$21.80M
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the externa...[Read more]
Industry
Biotechnology
IPO Date
2005-10-26
Stock Exchange
AMEX
Ticker
NNVC
According to NanoViricides, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.06. This represents a change of -47.37% compared to the average of 2.01 of the last 4 quarters.
The mean historical Current Ratio of NanoViricides, Inc. over the last ten years is 13.76. The current 1.06 Current Ratio has changed 669.66% with respect to the historical average. Over the past ten years (40 quarters), NNVC's Current Ratio was at its highest in in the June 2021 quarter at 59.30. The Current Ratio was at its lowest in in the December 2019 quarter at 0.35.
Average
13.76
Median
5.07
Minimum
0.99
Maximum
59.30
Discovering the peaks and valleys of NanoViricides, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 814.35%
Maximum Annual Current Ratio = 59.30
Minimum Annual Increase = -93.14%
Minimum Annual Current Ratio = 0.99
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 1.28 | -65.04% |
| 2024 | 3.66 | -76.86% |
| 2023 | 15.81 | -54.73% |
| 2022 | 34.92 | -41.11% |
| 2021 | 59.30 | 814.35% |
| 2020 | 6.49 | 553.79% |
| 2019 | 0.99 | -88.05% |
| 2018 | 8.30 | 153.33% |
| 2017 | 3.28 | -9.35% |
| 2016 | 3.62 | -93.14% |
The current Current Ratio of NanoViricides, Inc. (NNVC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.91
5-year avg
22.99
10-year avg
13.76
NanoViricides, Inc.’s Current Ratio is less than Verrica Pharmaceuticals Inc. (1.25), less than Jasper Therapeutics, Inc. (2.10), less than SAB Biotherapeutics, Inc. (10.50), less than Generation Bio Co. (7.51), less than Evaxion Biotech A/S (3.42), less than IGC Pharma, Inc. (1.32), less than Q32 Bio Inc. (4.57), less than MAIA Biotechnology, Inc. (2.19), less than AN2 Therapeutics, Inc. (31.96), less than Tenax Therapeutics, Inc. (41.89),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.25 | $79.91M | |
| 2.10 | $30.23M | |
| 10.50 | $36.32M | |
| 7.51 | $35.17M | |
| 3.42 | $33.41M | |
| 1.32 | $26.04M | |
| 4.57 | $44.54M | |
| 2.19 | $44.44M | |
| 31.96 | $29.18M | |
| 41.89 | $42.66M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NanoViricides, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NanoViricides, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is NanoViricides, Inc.'s Current Ratio?
How is the Current Ratio calculated for NanoViricides, Inc. (NNVC)?
What is the highest Current Ratio for NanoViricides, Inc. (NNVC)?
What is the 3-year average Current Ratio for NanoViricides, Inc. (NNVC)?
What is the 5-year average Current Ratio for NanoViricides, Inc. (NNVC)?
How does the current Current Ratio for NanoViricides, Inc. (NNVC) compare to its historical average?